CI Financial Corp.

OTCPK:CIXX.F Stock Report

Market Cap: US$2.4b

CI Financial Valuation

Is CIXX.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CIXX.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CIXX.F ($17.12) is trading above our estimate of fair value ($7.49)

Significantly Below Fair Value: CIXX.F is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CIXX.F?

Key metric: As CIXX.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CIXX.F. This is calculated by dividing CIXX.F's market cap by their current revenue.
What is CIXX.F's PS Ratio?
PS Ratio0.9x
SalesCA$3.59b
Market CapCA$3.40b

Price to Sales Ratio vs Peers

How does CIXX.F's PS Ratio compare to its peers?

The above table shows the PS ratio for CIXX.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.6x
FHI Federated Hermes
2.1x4.5%US$3.3b
PAX Patria Investments
5.8x15.5%US$1.9b
WT WisdomTree
4.2x8.6%US$1.7b
DBRG DigitalBridge Group
2.4x-11.5%US$2.2b
CIXX.F CI Financial
0.9x-3.1%US$3.4b

Price-To-Sales vs Peers: CIXX.F is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (3.6x).

Price to Sales Ratio vs Industry

How does CIXX.F's PS Ratio compare vs other companies in the US Capital Markets Industry?

23 CompaniesPrice / SalesEstimated GrowthMarket Cap
SNEX StoneX Group
0.03xn/aUS$3.27b
OPY Oppenheimer Holdings
0.5xn/aUS$635.07m
BKKT Bakkt Holdings
0.1x-151.2%US$420.36m
MKTW MarketWise
0.06x-3.5%US$180.58m
CIXX.F 0.9xIndustry Avg. 3.5xNo. of Companies23PS03.26.49.612.816+
23 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CIXX.F is good value based on its Price-To-Sales Ratio (0.9x) compared to the US Capital Markets industry average (3.5x).

Price to Sales Ratio vs Fair Ratio

What is CIXX.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CIXX.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.9x
Fair PS Ratio2.6x

Price-To-Sales vs Fair Ratio: CIXX.F is good value based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (2.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CIXX.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$17.12
US$17.93
+4.8%
15.2%US$19.98US$11.42n/a8
Nov ’25US$16.47
US$16.30
-1.0%
14.2%US$19.35US$11.46n/a8
Oct ’25US$13.63
US$14.32
+5.1%
10.9%US$16.36US$11.90n/a8
Sep ’25US$12.89
US$14.32
+11.1%
10.9%US$16.36US$11.90n/a8
Aug ’25US$12.00
US$13.80
+15.0%
9.7%US$15.16US$11.55n/a9
Jul ’25US$10.44
US$13.90
+33.1%
10.2%US$15.36US$11.70n/a9
Jun ’25US$10.76
US$13.90
+29.2%
10.2%US$15.36US$11.70n/a9
May ’25US$12.17
US$14.41
+18.4%
10.2%US$16.71US$11.62n/a9
Apr ’25US$12.68
US$14.27
+12.6%
10.3%US$17.03US$11.85n/a9
Mar ’25US$12.52
US$14.27
+14.0%
10.3%US$17.03US$11.85n/a9
Feb ’25US$12.15
US$13.50
+11.1%
8.2%US$15.68US$11.95n/a7
Jan ’25US$11.26
US$13.00
+15.5%
11.0%US$15.67US$11.19n/a7
Dec ’24US$10.60
US$12.52
+18.1%
9.6%US$14.48US$10.86n/a7
Nov ’24US$9.24
US$12.56
+35.9%
9.6%US$14.47US$10.85US$16.477
Oct ’24US$11.41
US$14.20
+24.4%
9.9%US$16.20US$11.78US$13.637
Sep ’24US$12.89
US$14.32
+11.1%
9.3%US$16.36US$11.90US$12.898
Aug ’24US$12.33
US$14.72
+19.4%
11.6%US$18.06US$12.04US$12.009
Jul ’24US$11.35
US$13.79
+21.5%
15.9%US$17.04US$10.00US$10.449
Jun ’24US$9.88
US$13.79
+39.6%
15.9%US$17.04US$10.00US$10.769
May ’24US$9.90
US$13.93
+40.6%
9.8%US$16.49US$11.73US$12.179
Apr ’24US$9.37
US$14.16
+51.1%
10.8%US$17.31US$11.79US$12.689
Mar ’24US$11.10
US$14.16
+27.6%
10.8%US$17.31US$11.79US$12.529
Feb ’24US$12.20
US$14.26
+16.9%
11.0%US$17.31US$12.04US$12.159
Jan ’24US$9.99
US$13.66
+36.7%
11.8%US$16.59US$12.07US$11.269
Dec ’23US$10.81
US$13.66
+26.3%
11.8%US$16.59US$12.07US$10.609
Nov ’23US$10.13
US$13.42
+32.4%
12.3%US$16.15US$11.01US$9.249

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Investor

SEK 906.7b

A private equity firm specializing in mature, middle market, buyouts and growth capital investments.

IVSB.F

SEK 26.00

7D

-3.9%

1Y

28.7%

FinVolution Group

US$1.6b

Operates in the online consumer finance industry.

FINV

US$6.29

7D

8.1%

1Y

38.5%

ORIX

JP¥3.8t

Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.

IX

JP¥107.82

7D

-0.5%

1Y

18.6%